Medical thoracoscopy: Hormone receptor content in pleural metastases due to breast cancer

European Respiratory Journal

Volumn 24, Issue 5, 2004, Pages 728-730

  Schwarz, C ^a   Lubbert H ^c   Rahn, W ^b   Schonfeld N ^a   Serke, M ^a   Loddenkemper, R ^a  

^a Zentralklinik Emil von Behring ^*  (Germany)

^b Institute of Pathology   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast cancer; Malignant pleural effusion; Medical thoracoscopy; Oestrogen and progesterone receptors

Indexed keywords

CHARCOAL; DEXTRAN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; LIQUID NITROGEN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASSAY; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PLEURA EFFUSION; PLEURA METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; SCATCHARD PLOT; SCORING SYSTEM; THORACOSCOPY; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PLEURAL NEOPLASMS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; THORACOSCOPY;

EID: 8644268077     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00069104     Document Type: Article

References (30)

1. Weichselbaum R, Marck A, Hellman S. Pathogenesis of pleural effusion in carcinoma of the breast. Int J Radiat Oncol Biol Phys 1977; 2: 963-965.
2. Kreisman H, Wolkove N, Schwartz Finkelstein H, Cohen C, Margolese R, Frank H. Breast cancer and thoracic metastases: review of 119 patients. Thorax 1983; 38: 175-179.
3. Fracchia AA, Knapper WH, Carey JT, Farrow JH. Intrapleural chemotherapy for effusion from metastatic breast carcinoma. Cancer 1970; 26: 626-629.
4. Fentiman IS, Rubens Rd, Hayward JL. Control of pleural effusions in patients with breast cancer. A randomized trial. Cancer 1981; 52: 737-739.
5. Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS. Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 1983; 309: 1343-1347.
6. Kamby C, Rose C, Iversen H, Holm NY, Andersen KW, Thorpe SM. Pattern of metastases in human breast carcinoma in relation to estrogen receptor status. Anticancer Res 1986; 6: 107-112.
7. Loddenkemper R. Thoracoscopy: state of the art. Eur Respir J 1998; 11: 213-221.
8. Al Saati T, Clamens S, Cohen-Knafo E, et al. Production of monoclonal antibodies to human estrogen receptor (ER) protein using recombinant ER (RER). Int J Cancer 1993; 55: 651-654.
9. Kraus WL, Montano MM, Katzenellenbogen BS. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol Endocrinol 1993; 7: 1603-1616.
10. Remmle W, Stegner HE. Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138-140.
11. Scatchard DG. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-663.
12. Levine MN, Young JEM, Ryan ED, Newhouse MT. Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination. Cancer 1986; 57: 324-327.
13. Rosen PP, Menendez-Botet CJ, Urban JA, Fracchia A, Schwartz MK. Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer. Cancer 1977; 39: 2194-2200.
14. Webster DJ, Bronn DG, Minton JP. Estrogen receptor levels in multiple biopsies from patients with breast cancer. Am J Surg 1978; 136: 337-338.
15. Hoehn JL, Plotka ED, Dickson KB. Comparison of estrogen receptor levels and regional metastatic carcinoma of the breast. Ann Surg 1979; 190: 69-71.
16. Brennan MJ, Donegan WL, Appleby DE. The variability of estrogen receptors in metastatic breast cancer. Am J Surg 1979; 137: 260-262.
17. Klinga K, Kaufmann M, Runnebaum B, Kubli F. Distribution of estrogen and progesterone receptors on primary tumor and lymph nodes in individual patients with breast cancer. Oncology 1982; 39: 337-339.
18. Holdaway IM, Bowditch JV. Variation in receptor status between primary and metastatic breast cancer. Cancer 1983; 52: 479-485.
19. Jakesz R, Dittrich C, Hanusch J, et al. Simultaneous and sequential determination of steroid hormone receptors in human breast cancer. Influence of intervening therapy. Ann Surg 1985; 201: 305-310.
20. Alanko A. Variation of estrogen and progesterone receptor status in breast cancer. Ann Clin Res 1985; 17: 10-14.
21. Andersen J, Poulsen HS. Relationship between estrogen receptor status in the primary tumor and its regional and distant metastases. An immunohistochemical study in human breast cancer. Acta Oncol 1988; 27: 761-765.
22. Kamby C, Rasmussen BB, Kristensen B. Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer 1989; 60: 252-257.
23. Li BD, Byskosh A, Molteni A, Duda RB. Estrogen and progesterone receptor concordance between primary and recurrent breast cancer. J Surg Oncol 1994; 57: 71-77.
24. Kuukasjärvi T, Kononen J, Helin H, Holli K, Isola J. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol 1996; 14: 2584-2589.
25. Fentiman IS, Rubens RD, Haward JL. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol 1986; 22: 1079.
26. Hamed H, Fentiman IS, Chaudary MA, et al. Comparison of intracavitary bleomycin and talc for control of pleural effusion secondary to carcinoma of the breast. Br J Surg 1989; 76: 1266.
27. American Thoracic Society. Management of malignant pleural effusion. Am J Respir Crit Care Med 2000; 162: 1987-2001.
28. Collett K, Hartveit F, Skjaerven R, Machle BO. Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status. J Clin Pathol 1996; 49: 920-925.
29. Merkle E, Seidl I, Bahr I, et al. Long term study of the significance of hormone receptors as prognostic factors in breast cancer. Geburtshilfe Frauenheilkd 1990; 50: 528-532.
30. Taucher S, Rudas M, Mader RM, et al. Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klein Wochenschr 2004; 116: 26-31.